Last reviewed · How we verify
NCT06568133
Drug-drug Interaction Study Between UIC201603, and UIC201604
Phase 1 trial testing UIC201603 and co-administration of UIC201603 and UIC201604 in Healthy in 57 participants. Completed in 7 February 2018.
4 July 2017
Quick facts
| Lead sponsor | Korea United Pharm. Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | other |
| Enrollment | 57 |
| Start date | 15 March 2017 |
| Primary completion | 4 July 2017 |
| Estimated completion | 7 February 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- UIC201603 and co-administration of UIC201603 and UIC201604 — full drug profile →
- UIC201604 and co-administration of UIC201603 and UIC201604 — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Korea United Pharm. Inc. — full company profile →
Who can join
Adults 19 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An open-label, multiple-dosing, two-arms, one-sequence study to evaluate the safety and pharmacokinetics after co-administration of UIC201603 and UIC201604 in healthy volunteers
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants.
Kim DH, Hong JH, Jung WT, Nam KY, et al · · 2025 · cited 1× · PMID 39487337 · DOI 10.1007/s40256-024-00686-w
Verify or expand the search:
- PubMed search for NCT06568133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Korea United Pharm. Inc. trials
Trials by the same sponsor.
- NCT07162441 — A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and · Phase 1 · recruiting
- NCT07110740 — Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects · Phase 1 · completed
- NCT06393881 — A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201 · Phase 1 · not yet recruiting
- NCT06141577 — A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects · Phase 1 · completed
- NCT06141590 — A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditio · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06568133 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korea United Pharm. Inc.
- Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06568133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing